Gan & Lee Pharmaceuticals Shandong Co., Ltd.,

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes4 trials

Phase

• Phase 33 trials
• Phase 11 trial

Status

• Active, not recruiting2 trials
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Gan & Lee Pharmaceuticals.4 trials

Running trials

• Not yet recruiting

  Bioequivalence Study of GZR4 Injection With Different Manufacturing Processes in Healthy Adult Participants

  NCT07670897· Phase 1· Gan & Lee Pharmaceuticals.· Source

  Contact: Yunda Zhuge

• Recruiting

  A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

  NCT07165223· Phase 3· Gan & Lee Pharmaceuticals.· Source

  Contact: juan wu

• Active, not recruiting

  A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)

  NCT06767735· Phase 3· Gan & Lee Pharmaceuticals.· Source

• Active, not recruiting

  A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

  NCT06767748· Phase 3· Gan & Lee Pharmaceuticals.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 2 diabetes2 recruiting